source
- Optogenetics therapy restores light sensitivity in half of retinitis pigmentosa patients in early trialA small clinical study examined an optogenetics‑based approach for treating retinitis pigmentosa, a genetic disorder that progressively destroys retinal light‑sensing cells and often leads to legal…
- Dutch court orders Merck to halt subcutaneous Keytruda sales in eight European countriesA Dutch court has issued an injunction that requires Merck to stop manufacturing and selling the injectable, subcutaneous formulation of its cancer immunotherapy Keytruda in eight European countrie…